Your browser doesn't support javascript.
loading
Rhabdomyolysis Following Initiation of Posaconazole Use for Antifungal Prophylaxis in a Patient With Relapsed Acute Myeloid Leukemia: A Case Report.
Mody, Mayur D; Ravindranathan, Deepak; Gill, Harpaul S; Kota, Vamsi K.
Afiliação
  • Mody MD; Emory University, Atlanta, GA, USA.
  • Ravindranathan D; Emory University, Atlanta, GA, USA.
  • Gill HS; Emory University, Atlanta, GA, USA.
  • Kota VK; Emory University, Atlanta, GA, USA.
J Investig Med High Impact Case Rep ; 5(1): 2324709617690747, 2017.
Article em En | MEDLINE | ID: mdl-28203579
Posaconazole is a commonly used medication for antifungal prophylaxis in patients with high-risk acute leukemia, such as acute myeloid leukemia. Despite clinical data that show that posaconazole is superior to other antifungal prophylaxis medications, posaconazole is known to have many side effects and drug-drug interactions. We present a patient who developed rhabdomyolysis after being started on posaconazole for prophylaxis in the setting of relapsed acute myeloid leukemia.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2017 Tipo de documento: Article